Fulvic acid in shilajit: what it is and what it actually does

Fulvic acid is the compound brands point to when they explain why shilajit supposedly works. It is genuinely interesting chemistry, and it is also where a lot of marketing overreaches. This guide separates what fulvic acid is and does in the lab from what has actually been shown in people, which turns out to be a much shorter list.

What fulvic acid is

Fulvic acid is a humic substance: one of the large, mixed family of organic molecules produced when plant and microbial matter decomposes. Within that family, fulvic acid is the small, water-soluble fraction. It stays soluble across the whole pH range, which distinguishes it from humic acid, the larger fraction that only dissolves at higher pH. Shilajit is essentially a rock-trapped humic material, and fulvic acid is the part of it that dissolves readily in water.

Humic substances are the large heterogeneous organic molecules formed by decomposition of plant and microbial matter, and fulvic acid is the smaller water-soluble fraction that stays soluble across the whole pH range. [Carrasco-Gallardo 2012] Moderate evidence

An important caveat sits underneath everything that follows. Humic substances have no single standardised structure. What counts as fulvic acid depends on where it came from and how it was extracted, which is a core reason the research on it is so inconsistent and hard to compare study to study.

Humic substances have no standardised single structure; composition depends on source and extraction, which is a key reason the evidence on fulvic acid is inconsistent. [Winkler & Ghosh 2018] Moderate evidence

The mechanisms researchers study

Most of the interest in fulvic acid comes from mechanisms observed in test tubes and animals. These are worth understanding, but read them as laboratory findings, not as proven human benefits.

Fulvic acid is redox-active, able to both donate and accept electrons, and can reduce pro-inflammatory cytokines such as TNF-alpha, though the same review notes it can also increase oxidative stress in some settings. [Winkler & Ghosh 2018] Preliminary evidence

That last point matters and is usually left out of marketing: fulvic acid is not uniformly an antioxidant. In some conditions it behaves the other way and increases oxidative stress. The rest of the mechanistic picture is similar in character, interesting but early.

Proposed effects of fulvic acid on mitochondrial respiration come only from in-vitro rat mitochondrial studies, with no human confirmation. [Winkler & Ghosh 2018] Preliminary evidence

Suggestions that fulvic acid enhances mineral and nutrient transport come from cell and animal feeding studies and have not been demonstrated in humans. [Winkler & Ghosh 2018] Preliminary evidence

The idea that fulvic acid modulates the gut microbiome rests on essentially a single animal study, with no human data. [Winkler & Ghosh 2018] Preliminary evidence

The Alzheimer’s mechanism, in context

You will sometimes see fulvic acid linked to Alzheimer’s disease. The basis for that is one laboratory observation: in a test tube, fulvic acid interfered with the self-aggregation of tau protein, a process involved in the disease. It is a molecular finding of interest, and nothing more than that. It is not evidence that shilajit or fulvic acid prevents or treats dementia in people.

Fulvic acid inhibited the self-aggregation of tau protein in vitro, a molecular finding of interest that is not evidence shilajit prevents or treats dementia. [Carrasco-Gallardo 2012] Preliminary evidence

The one human trial people cite, and why it does not fit

When marketers want a human study, they often reach for a small eczema trial. It is worth reading carefully, because it does not say what it is used to imply. The trial tested a topical cream, applied to the skin, made from carbohydrate-derived fulvic acid. It was not oral shilajit and it was not a supplement you swallow.

A small randomised trial found topical 3.5 percent carbohydrate-derived fulvic acid cream improved eczema severity versus placebo over four weeks, with only mild transient burning reported. [Gandy 2011] Moderate evidence

That result is fine on its own terms for a skin cream. It says nothing about ingesting shilajit, and citing it as proof that oral fulvic acid works is one of the more common mis-uses in this space.

What the research does not support

Put the pieces together and the honest bottom line is straightforward: fulvic acid is mechanistically interesting and clinically unproven in humans. The main review on it concedes the supporting literature is minimal, notes there are no large human trials, and points out there is no established safe dosing across age groups. Because composition varies by origin, even the studies that exist are hard to line up against each other.

The main review on fulvic acid concedes the supporting human literature is minimal, with no large human trials and no established safe dosing across age groups. [Winkler & Ghosh 2018] Insufficient evidence

• Antioxidant and anti-inflammatory activity: mostly test-tube and animal, and not uniform.
• Mitochondrial and nutrient-transport effects: cell and animal only.
• Gut and tau-protein findings: single studies or in-vitro work.
• The eczema trial: topical skin cream, not an oral supplement.

Fulvic acid is a real compound with a coherent chemistry story. What it does not yet have is a body of human trials showing that swallowing it produces the benefits attached to it. For how this fits into shilajit as a whole, see the science hub and our guide to what shilajit actually is. If you are weighing a purchase, the buying guide covers why label potency figures are unreliable.

References

1. Winkler J, Ghosh S. Therapeutic potential of fulvic acid in chronic inflammatory diseases and diabetes. J Diabetes Res. 2018;2018:5391014. PMC6151376
2. Carrasco-Gallardo C, et al. Shilajit: a natural phytocomplex with potential procognitive activity. Int J Alzheimers Dis. 2012;2012:674142. PMC3296184
3. Gandy JJ, Snyman JR, van Rensburg CEJ. Randomized study to evaluate carbohydrate-derived fulvic acid in topical treatment of eczema. Clin Cosmet Investig Dermatol. 2011;4:145-8. PMC3173016